1Belluzzi, A (2002) n-3 Fatty acids for the treatment of inflammatory bowel diseases. Proc Nutr Soc 61, 391–395.
2Nishida, T, Miwa, H, Shigematsu, A, Yamamoto, M, Iida, M & Fujishima, M (1987) Increased arachidonic acid composition of phospholipids in colonic mucosa from patients with active ulcerative colitis. Gut 28, 1002–1007.
3Buhner, S, Nagel, E, Korber, J, Vogelsang, H, Linn, T & Pichlmayr, R (1994) Ileal and colonic fatty acid profiles in patients with active Crohn's disease. Gut 35, 1424–1428.
4Pacheco, S, Hillier, K & Smith, C (1987) Increased arachidonic acid levels in phospholipids of human colonic mucosa in inflammatory bowel disease. Clin Sci (Lond) 73, 361–364.
5Hawthorne, AB, Daneshmend, TK, Hawkey, CJ, Belluzzi, A, Everitt, SJ, Holmes, GK, Malkinson, C, Shaheen, MZ & Willars, JE (1992) Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial. Gut 33, 922–928.
6Ramakers, JD, Mensink, RP, Schaart, G & Plat, J (2007) Arachidonic acid but not eicosapertaenoic acid (EPA) and oleic acid activates NF-kappaB and elevates ICAM-1 expression in Caco-2 cells. Lipids 42, 687–698.
7Belluzzi, A, Brignola, C, Campieri, M, Pera, A, Boschi, S & Miglioli, M (1996) Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N Engl J Med 334, 1557–1560.
8Stenson, WF, Cort, D, Rodgers, J, Burakoff, R, DeSchryver-Kecskemeti, K, Gramlich, TL & Beeken, W (1992) Dietary supplementation with fish oil in ulcerative colitis. Ann Intern Med 116, 609–614.
9Almallah, YZ, El-Tahir, A, Heys, SD, Richardson, S & Eremin, O (2000) Distal procto-colitis and n-3 polyunsaturated fatty acids: the mechanism(s) of natural cytotoxicity inhibition. Eur J Clin Invest 30, 58–65.
10Salomon, P, Kornbluth, AA & Janowitz, HD (1990) Treatment of ulcerative colitis with fish oil n-3-omega-fatty acid: an open trial. J Clin Gastroenterol 12, 157–161.
11McCall, TB, O'Leary, D, Bloomfield, J & O'Morain, CA (1989) Therapeutic potential of fish oil in the treatment of ulcerative colitis. Aliment Pharmacol Ther 3, 415–424.
12Lorenz-Meyer, H, Bauer, P, Nicolay, C, Schulz, B, Purmann, J, Fleig, WE, Scheurlen, C, Koop, I, Pudel, V & Carr, L (1996) Omega-3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease. A randomized controlled multicenter trial. Study Group Members (German Crohn's Disease Study Group). Scand J Gastroenterol 31, 778–785.
13Loeschke, K, Ueberschaer, B, Pietsch, A, Gruber, E, Ewe, K, Wiebecke, B, Heldwein, W & Lorenz, R (1996) n-3 Fatty acids only delay early relapse of ulcerative colitis in remission. Dig Dis Sci 41, 2087–2094.
14Lorenz, R, Weber, PC, Szimnau, P, Heldwein, W, Strasser, T & Loeschke, K (1989) Supplementation with n-3 fatty acids from fish oil in chronic inflammatory bowel disease – a randomized, placebo-controlled, double-blind cross-over trial. J Intern Med Suppl 731, 225–232.
15Dichi, I, Frenhane, P, Dichi, JB, Correa, CR, Angeleli, AY, Bicudo, MH, Rodrigues, MA, Victoria, CR & Burini, RC (2000) Comparison of omega-3 fatty acids and sulfasalazine in ulcerative colitis. Nutrition 16, 87–90.
16Aslan, A & Triadafilopoulos, G (1992) Fish oil fatty acid supplementation in active ulcerative colitis: a double-blind, placebo-controlled, crossover study. Am J Gastroenterol 87, 432–437.
17Nieto, N, Torres, MI, Rios, A & Gil, A (2002) Dietary polyunsaturated fatty acids improve histological and biochemical alterations in rats with experimental ulcerative colitis. J Nutr 132, 11–19.
18Camuesco, D, Galvez, J, Nieto, A, Comalada, M, Rodriguez-Cabezas, ME, Concha, A, Xaus, J & Zarzuelo, A (2005) Dietary olive oil supplemented with fish oil, rich in EPA and DHA (n-3) polyunsaturated fatty acids, attenuates colonic inflammation in rats with DSS-induced colitis. J Nutr 135, 687–694.
19Empey, LR, Jewell, LD, Garg, ML, Thomson, AB, Clandinin, MT & Fedorak, RN (1991) Fish oil-enriched diet is mucosal protective against acetic acid-induced colitis in rats. Can J Physiol Pharmacol 69, 480–487.
20Yuceyar, H, Ozutemiz, O, Huseyinov, A, Saruc, M, Alkanat, M, Bor, S, Coker, I & Batur, Y (1999) Is administration of n-3 fatty acids by mucosal enema protective against trinitrobenzene-induced colitis in rats? Prostaglandins Leukot Essent Fatty Acids 61, 339–345.
21Guarner, F, Vilaseca, J & Malagelada, JR (1992) Dietary manipulation in experimental inflammatory bowel disease. Agents Actions , C10–C14.
22Whiting, CV, Bland, PW & Tarlton, JF (2005) Dietary n-3 polyunsaturated fatty acids reduce disease and colonic proinflammatory cytokines in a mouse model of colitis. Inflamm Bowel Dis 11, 340–349.
23Vilaseca, J, Salas, A, Guarner, F, Rodriguez, R, Martinez, M & Malagelada, JR (1990) Dietary fish oil reduces progression of chronic inflammatory lesions in a rat model of granulomatous colitis. Gut 31, 539–544.
24Tenikoff, D, Murphy, KJ, Le, M, Howe, PR & Howarth, GS (2005) Lyprinol (stabilised lipid extract of New Zealand green-lipped mussel): a potential preventative treatment modality for inflammatory bowel disease. J Gastroenterol 40, 361–365.
25Hegazi, RA, Saad, RS, Mady, H, Matarese, LE, O'Keefe, S & Kandil, HM (2006) Dietary fatty acids modulate chronic colitis, colitis-associated colon neoplasia and COX-2 expression in IL-10 knockout mice. Nutrition 22, 275–282.
26Wensing, AG, Mensink, RP & Hornstra, G (1999) Effects of dietary n-3 polyunsaturated fatty acids from plant and marine origin on platelet aggregation in healthy elderly subjects. Br J Nutr 82, 183–191.
27Bligh, EG & Dyer, WJ (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37, 911–917.
28Kaluzny, MA, Duncan, LA, Merritt, MV & Epps, DE (1985) Rapid separation of lipid classes in high yield and purity using bonded phase columns. J Lipid Res 26, 135–140.
29Morrison, WR & Smith, LM (1964) Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride–methanol. J Lipid Res 5, 600–608.
30Daemen, MA, Heemskerk, VH, van't Veer, C, Denecker, G, Wolfs, TG, Vandenabeele, P & Buurman, WA (2000) Functional protection by acute phase proteins α(1)-acid glycoprotein and α(1)-antitrypsin against ischemia/reperfusion injury by preventing apoptosis and inflammation. Circulation 102, 1420–1426.
31Cooper, HS, Murthy, SN, Shah, RS & Sedergran, DJ (1993) Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 69, 238–249.
32Serhan, CN (2005) Novel eicosanoid and docosanoid mediators: resolvins, docosatrienes, and neuroprotectins. Curr Opin Clin Nutr Metab Care 8, 115–121.
33Bassaganya-Riera, J, Reynolds, K, Martino-Catt, S, Cui, Y, Hennighausen, L, Gonzalez, F, Rohrer, J, Benninghoff, AU & Hontecillas, R (2004) Activation of PPAR γ and δ by conjugated linoleic acid mediates protection from experimental inflammatory bowel disease. Gastroenterology 127, 777–791.
34Whelan, J, Surette, ME, Hardardottir, I, Lu, G, Golemboski, KA, Larsen, E & Kinsella, JE (1993) Dietary arachidonate enhances tissue arachidonate levels and eicosanoid production in Syrian hamsters. J Nutr 123, 2174–2185.
35Mohrhauer, H & Holman, RT (1963) The effect of dose level of essential fatty acids upon fatty acid composition of the rat liver. J Lipid Res 4, 151–159.
36Danon, A, Heimberg, M & Oates, JA (1975) Enrichment of rat tissue lipids with fatty acids that are prostaglandin precursors. Biochim Biophys Acta 388, 318–330.
37Leaf, A & Weber, PC (1988) Cardiovascular effects of n-3 fatty acids. N Engl J Med 318, 549–557.
38Kinsella, JE, Lokesh, B, Broughton, S & Whelan, J (1990) Dietary polyunsaturated fatty acids and eicosanoids: potential effects on the modulation of inflammatory and immune cells: an overview. Nutrition 6, 24–44; .
39Kwon, KH, Murakami, A, Tanaka, T & Ohigashi, H (2005) Dietary rutin, but not its aglycone quercetin, ameliorates dextran sulfate sodium-induced experimental colitis in mice: attenuation of pro-inflammatory gene expression. Biochem Pharmacol 69, 395–406.
40Anonymous (2004) Suppressive activity of a fermented grain food product on dextran sulfate sodium-induced experimental colitis in mice. Biofactors 21, 179–184.
41Liu, C, Russell, RM, Smith, DE, Bronson, RT, Milbury, PE, Furukawa, S, Wang, XD & Blumberg, JB (2004) The effect of dietary glutathione and coenzyme Q10 on the prevention and treatment of inflammatory bowel disease in mice. Int J Vitam Nutr Res 74, 74–85.
42Micallef, MJ, Iwaki, K, Ishihara, T, Ushio, S, Aga, M, Kunikata, T, Koya-Mitaya, S, Kimoto, T, Ikeda, M & Kurimoto, M (2002) The natural plant product tryptanthrin ameliorates dextran sodium sulfate-induced colitis in mice. Int Immunopharmacol 2, 565–578.
43Lawson, LD & Hughes, BG (1988) Human absorption of fish oil fatty acids as triacylglycerols, free acids, or ethyl esters. Biochem Biophys Res Commun 152, 328–335.
44Anonymous (1988) Absorption of eicosapentaenoic acid and docosahexaenoic acid from fish oil triacylglycerols or fish oil ethyl esters co-ingested with a high-fat meal. Biochem Biophys Res Commun 156, 960–963.
45el Boustani, S, Colette, C, Monnier, L, Descomps, B, Crastes de Paulet, A & Mendy, F (1987) Enteral absorption in man of eicosapentaenoic acid in different chemical forms. Lipids 22, 711–714.
46Anonymous (1999) Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 354, 447–455.